Login | Register

Late Stage Lung Cancer Drug Gilotrif (Afatinib) Approved By FDA

The FDA has approved the use of Gilotrif (afatinib) to treat patients with non-small cell lung cancer (NSCLC) who have certain epidermal growth factor receptor (EGFR) gene mutations in their tumors. Lung cancer is one of the leading cancer-killers, with an estimated 159,480 people dying from the disease this year in the U.S. alone...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *